Home › Cell Therapeutics soars 24 percent after drug deal with Baxter
 

Keywords :   


Cell Therapeutics soars 24 percent after drug deal with Baxter

2013-11-16 09:10:33| Biotech - Topix.net

The two companies agreed to jointly develop and market the drug, which is being tested in a late-stage trial, in a deal that could fetch Cell Therapeutics' up to $362 million, including an equity investment by Baxter.

Tags: with cell deal drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.05Dantex announces new digital director for Pico division
13.05Tonny De Beer Joins First Quality
13.05Join us for the 2024 Global Hog Industry Virtual Conference
13.05New version of Chat-GPT can teach maths and flirt
13.05Eastern North Pacific Tropical Weather Outlook
13.05Melinda French Gates to quit Gates Foundation
13.05BASF in South Carolina Joins with Make-A-Wish
13.05PCMC addresses latest printing trends at \'Power Packs Live\'
More »